Company Filing History:
2 out of 4,447 
1 out of 5,309 
Years Active: 1993-1998
Title: Leslie M McEvoy: Innovator in Medical Research
Introduction
Leslie M McEvoy is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of medical research, particularly in the area of endothelial cell adhesion and atherosclerotic disease. With a total of 3 patents, her work has had a profound impact on diagnosis and therapy in these critical areas.
Latest Patents
One of her latest patents focuses on endothelial cell adhesion molecules. This invention provides methods and compositions for modulating monocyte binding to endothelial cells, especially during inflammatory episodes. The compositions bind to monocyte surface membrane proteins or endothelial surface membrane proteins, facilitating the adhesion of monocytes to endothelial cells. These compositions can be utilized in both diagnosis and therapy. Another significant patent involves monoclonal antibodies reactive with a human atheroma-associated antigen. This invention relates to a naturally occurring, minimally modified LDL antigen found in human atherosclerotic lesions and in the serum of many patients with coronary artery disease. The patent also includes antibodies reactive with the antigen, hybridoma cell lines that produce these antibodies, and methods for their use in diagnosing and treating atherosclerotic disease.
Career Highlights
Leslie has worked with notable organizations such as Eli Lilly and Company and Leland Stanford Junior University. Her experience in these institutions has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Throughout her career, Leslie has collaborated with esteemed colleagues, including Thomas F Bumol and Eugene C Butcher. These partnerships have further enriched her research and innovation efforts.
Conclusion
Leslie M McEvoy is a distinguished inventor whose work in medical research has led to important advancements in understanding and treating diseases related to endothelial cell adhesion and atherosclerosis. Her contributions continue to influence the field and improve patient outcomes.